%0 Journal Article
%A o‘g‘li, Amonov Botirali Baxrom
%A Abdurakhmonovna, Kibriyeva Maxfirat
%D 2026
%F arxiv:71112
%I "XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR" nomli respublika ilmiy-amaliy konferensiyasi
%J XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TAʼLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR nomli respublika ilmiy-amaliy konferensiyasi
%K arterial hypertension, hypotensive agents, vasopressors, inotropic drugs, RAAS, beta-blocker, ACE inhibitor, ARB, calcium channel blocker, safety and monitoring
%T HYPOTENSIVE AND HYPERTENSIVE AGENTS: MECHANISMS, DOSE–RESPONSE RELATIONSHIPS, CLINICAL USE, ADVERSE EFFECTS, AND SAFETY PRINCIPLES
%U https://arxiv.universalpublishings.com/id/eprint/71112/
%X Arterial blood pressure is determined by cardiac output and peripheral vascular resistance; these parameters are finely regulated through the renin–angiotensin–aldosterone system, the sympathetic nervous system, renal sodium–water handling, and endothelial mediators. For this reason, the pharmacology of hypotensive (blood-pressure–lowering) and hypertensive (blood-pressure–raising, pressor) agents cannot be reduced to the simple idea of “lowering or raising the number”: such agents influence the heart, kidneys, brain, and peripheral vessels through different pathways and serve distinct goals in acute and chronic clinical settings
%Z Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/16816)